Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ranibizumab (lucentis) (1 trial)
Diabetic Retinopathy (Phase 3)
Retinal Diseases (Phase 3)
Trials (1 total)
Trial APIs (1 total)